Literature DB >> 4826898

Changes in neostriatal DA metabolism after carbachol or atropine microinjections into the substantia nigra.

F Javoy, Y Agid, D Bouvet, J Glowinski.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4826898     DOI: 10.1016/0006-8993(74)90394-1

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


× No keyword cloud information.
  13 in total

Review 1.  Organization and physiology of the substantia nigra.

Authors:  H Condé
Journal:  Exp Brain Res       Date:  1992       Impact factor: 1.972

2.  The interaction of neuroleptic and muscarinic agents with central dopaminergic systems.

Authors:  P H Kelly; R J Miller
Journal:  Br J Pharmacol       Date:  1975-05       Impact factor: 8.739

3.  Early effects of monoamine oxidase inhibitors on dopamine metabolism and monoamine oxidase activity in the neostriatum of the rat.

Authors:  F Javoy; M B Youdim; Y Agid; J Glowinski
Journal:  J Neural Transm       Date:  1973       Impact factor: 3.575

4.  A role of the polysynaptic system of substantia nigra in the cholinergic-dopaminergic equilibrium in the central nervous system.

Authors:  S Wolfarth; E Dulska; K Gołembiowska-Nikitin; J Vetulani
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-04       Impact factor: 3.000

5.  Electrophysiological actions of nicotine on substantia nigra single units.

Authors:  P B Clarke; D W Hommer; A Pert; L R Skirboll
Journal:  Br J Pharmacol       Date:  1985-08       Impact factor: 8.739

6.  Interaction between cholinergic and catecholaminergic agents in a spontaneous alternation task.

Authors:  L Kokkinidis; H Anisman
Journal:  Psychopharmacology (Berl)       Date:  1976-08-17       Impact factor: 4.530

7.  The synaptic significance of metoclopramide induced dyskinetic-dystonic head and neck movements in pregnancy.

Authors:  J J Askenasy; M Streifler; S Felner
Journal:  J Neural Transm       Date:  1978       Impact factor: 3.575

8.  Increased CSF HVA response to arecoline challenge in Alzheimer's disease.

Authors:  N Pomara; M Stanley; P A LeWitt; M Galloway; R Singh; D Deptula
Journal:  J Neural Transm Gen Sect       Date:  1992

9.  Acetylcholinesterase neurons in dopamine-containing regions of the brain.

Authors:  L L Butcher; K Talbot; L Bilezikjian
Journal:  J Neural Transm       Date:  1975       Impact factor: 3.575

10.  Effects of central cholinergic blockade on striatal dopamine release measured with positron emission tomography in normal human subjects.

Authors:  S L Dewey; G S Smith; J Logan; J D Brodie; P Simkowitz; R R MacGregor; J S Fowler; N D Volkow; A P Wolf
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.